Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

Abstract Background The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is very poor. Currently, therapeutic methods for this patient population include whole-brain radiation therapy (WBRT), surgery, radiosurgery and systemic treatment. Epidermal growth factor receptor tyrosine...

Full description

Bibliographic Details
Main Authors: Kejun Liu, Guanming Jiang, Ailing Zhang, Zhuanghua Li, Jun Jia
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Cancer
Subjects:
Brain metastasis
EGFR mutation
Targeted therapy
Non-small-cell lung cancer (NSCLC)
Online Access:https://doi.org/10.1186/s12885-020-6543-y

Internet

https://doi.org/10.1186/s12885-020-6543-y

Similar Items